These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 8187332)

  • 1. Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.
    Soboslay PT; Lüder CG; Hoffmann WH; Michaelis I; Helling G; Heuschkel C; Dreweck CM; Blanke CH; Pritze S; Banla M
    Clin Exp Immunol; 1994 May; 96(2):238-44. PubMed ID: 8187332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.
    Soboslay PT; Geiger SM; Weiss N; Banla M; Lüder CG; Dreweck CM; Batchassi E; Boatin BA; Stadler A; Schulz-Key H
    Immunology; 1997 Apr; 90(4):592-9. PubMed ID: 9176114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoregulation in onchocerciasis: predominance of Th1-type responsiveness to low molecular weight antigens of Onchocerca volvulus in exposed individuals without microfilaridermia and clinical disease.
    Lüder CG; Schulz-Key H; Banla M; Pritze S; Soboslay PT
    Clin Exp Immunol; 1996 Aug; 105(2):245-53. PubMed ID: 8706329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.
    Mai CS; Hamm DM; Banla M; Agossou A; Schulz-Key H; Heuschkel C; Soboslay PT
    Clin Exp Immunol; 2007 Mar; 147(3):504-12. PubMed ID: 17302900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal immune priming in onchocerciasis-onchocerca volvulus-specific cellular responsiveness and cytokine production in newborns from infected mothers.
    Soboslay PT; Geiger SM; Drabner B; Banla M; Batchassi E; Kowu LA; Stadler A; Schulz-Key H
    Clin Exp Immunol; 1999 Jul; 117(1):130-7. PubMed ID: 10403926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory effects of Th1-type (IFN-gamma, IL-12) and Th2-type cytokines (IL-10, IL-13) on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controls.
    Soboslay PT; Lüder CG; Riesch S; Geiger SM; Banla M; Batchassi E; Stadler A; Schulz-Key H
    Immunology; 1999 Jun; 97(2):219-25. PubMed ID: 10447735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment.
    Soboslay PT; Dreweck CM; Hoffmann WH; Lüder CG; Heuschkel C; Görgen H; Banla M; Schulz-Key H
    Clin Exp Immunol; 1992 Sep; 89(3):407-13. PubMed ID: 1516257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo.
    Johanns SI; Gantin RG; Wangala B; Komlan K; Halatoko WA; Banla M; Karabou P; Luty AJ; Schulz-Key H; Köhler C; Soboslay PT
    PLoS Negl Trop Dis; 2022 May; 16(5):e0010340. PubMed ID: 35503786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental onchocerciasis in chimpanzees: cellular responses and antigen recognition after immunization and challenge with Onchocerca volvulus infective third-stage larvae.
    Lüder CG; Soboslay PT; Prince AM; Greene BM; Lucius R; Schulz-Key H
    Parasitology; 1993 Jul; 107 ( Pt 1)():87-97. PubMed ID: 8356001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental onchocerciasis in chimpanzees. Antibody response and antigen recognition after primary infection with Onchocerca volvulus.
    Soboslay PT; Weiss N; Dreweck CM; Taylor HR; Brotman B; Schulz-Key H; Greene BM
    Exp Parasitol; 1992 Jun; 74(4):367-80. PubMed ID: 1592090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential cytokine and antibody responses to adult and larval stages of Onchocerca volvulus consistent with the development of concomitant immunity.
    MacDonald AJ; Turaga PS; Harmon-Brown C; Tierney TJ; Bennett KE; McCarthy MC; Simonek SC; Enyong PA; Moukatte DW; Lustigman S
    Infect Immun; 2002 Jun; 70(6):2796-804. PubMed ID: 12010965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ivermectin-induced immunopotentiation in onchocerciasis: recognition of selected antigens following a single dose of ivermectin.
    Akuffo H; Maasho K; Lavebratt C; Engström K; Britton S
    Clin Exp Immunol; 1996 Feb; 103(2):244-52. PubMed ID: 8565307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immune responses in human infection with Onchocerca volvulus.
    Gallin M; Edmonds K; Ellner JJ; Erttmann KD; White AT; Newland HS; Taylor HR; Greene BM
    J Immunol; 1988 Mar; 140(6):1999-2007. PubMed ID: 3257994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onchocerca volvulus-exposed persons fail to produce interferon-gamma in response to O. volvulus antigen but mount proliferative responses with interleukin-5 and IL-13 production that decrease with increasing microfilarial density.
    Brattig NW; Lepping B; Timmann C; Büttner DW; Marfo Y; Hamelmann C; Horstmann RD
    J Infect Dis; 2002 Apr; 185(8):1148-54. PubMed ID: 11930325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin G subclass responses of children during infection with Onchocerca volvulus.
    Gbakima AA; Nutman TB; Bradley JE; McReynolds LA; Winget MD; Hong Y; Scott AL
    Clin Diagn Lab Immunol; 1996 Jan; 3(1):98-104. PubMed ID: 8770512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental onchocerciasis in chimpanzees. Cell-mediated immune responses, and production and effects of IL-1 and IL-2 with Onchocerca volvulus infection.
    Soboslay PT; Dreweck CM; Taylor HR; Brotman B; Wenk P; Greene BM
    J Immunol; 1991 Jul; 147(1):346-53. PubMed ID: 2051025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory effects of IL-12 and IL-18 on Onchocerca volvulus- and Entamoeba histolytica-specific cellular reactivity and cytokine profiles.
    Pfaff AW; Kirch AK; Hoffmann WH; Banla M; Schulz-Key H; Geiger SM; Soboslay PT
    Parasite Immunol; 2003 Jun; 25(6):325-32. PubMed ID: 14507330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific and sensitive IgG4 immunodiagnosis of onchocerciasis with a recombinant 33 kD Onchocerca volvulus protein (Ov33).
    Lucius R; Kern A; Seeber F; Pogonka T; Willenbücher J; Taylor HR; Pinder M; Ghalib HW; Schulz-Key H; Soboslay P
    Trop Med Parasitol; 1992 Sep; 43(3):139-45. PubMed ID: 1281926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of ivermectin treatment on the antibody response to antigens of Onchocerca volvulus.
    Gillespie AJ; Lustigman S; Rivas-Alcala AR; Bradley JE
    Trans R Soc Trop Med Hyg; 1994; 88(4):456-60. PubMed ID: 7570844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.
    Komlan K; Vossberg PS; Gantin RG; Solim T; Korbmacher F; Banla M; Padjoudoum K; Karabou P; Köhler C; Soboslay PT
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006312. PubMed ID: 29494606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.